Results for tag: "Neurological Dysfunction"

The Neurological Dysfunction market is a subset of the larger Neurology field, which focuses on the diagnosis and treatment of disorders of the nervous system. This market includes a range of products and services, such as drugs, medical devices, diagnostics, and services, that are used to treat neurological disorders. These products and services are used to treat a variety of neurological conditions, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. The Neurological Dysfunction market is highly competitive, with a number of companies offering products and services to treat neurological disorders. Some of these companies include AbbVie, Biogen, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more